ESR1 and breast cancer: Notably, overexpression of ESR1 promoted breast cancer cell proliferation, migration, and invasion; however, these results were reversed upon knocking down ESR1. The observed inhibitory effect of isorhamnetin on breast cancer cells was attributed to its ability to suppress ESR1 gene expression (22).